KR102549076B1 - Composition for skin whitening comprising mixture of fermented ginseng leaf extract and Miscanthus sinensis extract as effective component - Google Patents
Composition for skin whitening comprising mixture of fermented ginseng leaf extract and Miscanthus sinensis extract as effective component Download PDFInfo
- Publication number
- KR102549076B1 KR102549076B1 KR1020210127747A KR20210127747A KR102549076B1 KR 102549076 B1 KR102549076 B1 KR 102549076B1 KR 1020210127747 A KR1020210127747 A KR 1020210127747A KR 20210127747 A KR20210127747 A KR 20210127747A KR 102549076 B1 KR102549076 B1 KR 102549076B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- mixture
- ginseng leaf
- leaf extract
- skin whitening
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 84
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 241000208340 Araliaceae Species 0.000 title claims abstract description 44
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 44
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 44
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 44
- 230000002087 whitening effect Effects 0.000 title claims abstract description 22
- 241000878006 Miscanthus sinensis Species 0.000 title claims description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims abstract description 48
- 241000878007 Miscanthus Species 0.000 claims abstract description 36
- 239000004480 active ingredient Substances 0.000 claims abstract description 24
- 239000002537 cosmetic Substances 0.000 claims abstract description 20
- 235000013376 functional food Nutrition 0.000 claims abstract description 15
- 208000021710 Hyperpigmentation disease Diseases 0.000 claims abstract description 14
- 230000036541 health Effects 0.000 claims abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 208000003351 Melanosis Diseases 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 206010008570 Chloasma Diseases 0.000 claims description 9
- 239000000049 pigment Substances 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 241001468192 Leuconostoc citreum Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 206010014970 Ephelides Diseases 0.000 claims description 5
- 208000000069 hyperpigmentation Diseases 0.000 claims description 5
- 230000003810 hyperpigmentation Effects 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 206010061218 Inflammation Diseases 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 201000004624 Dermatitis Diseases 0.000 claims description 2
- 206010064127 Solar lentigo Diseases 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 102000003425 Tyrosinase Human genes 0.000 abstract description 19
- 108060008724 Tyrosinase Proteins 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 8
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 27
- 239000000047 product Substances 0.000 description 20
- -1 body cleanser Substances 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 7
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 7
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 6
- 108010051081 dopachrome isomerase Proteins 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 210000002752 melanocyte Anatomy 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- YFTGOBNOJKXZJC-UHFFFAOYSA-N 5,6-dihydroxyindole-2-carboxylic acid Chemical compound OC1=C(O)C=C2NC(C(=O)O)=CC2=C1 YFTGOBNOJKXZJC-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000020710 ginseng extract Nutrition 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000375 suspending agent Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- 235000012241 calcium silicate Nutrition 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- ZTBVJLXMEWWFHD-UHFFFAOYSA-N 2,3-dioxo-1h-indole-4-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=C1C(=O)C(=O)N2 ZTBVJLXMEWWFHD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 206010036229 Post inflammatory pigmentation change Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229960003340 calcium silicate Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006388 chemical passivation reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 244000291751 pluma del Caribe Species 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Abstract
본 발명은 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물을 유효성분으로 함유하는 피부 미백용 조성물에 관한 것으로, 상기 유효성분인 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물의 티로시나아제 억제 효과가 인삼잎 추출물의 발효물 또는 억새 추출물에 비해 현저한 효과가 있으므로, 상기 유효성분을 함유하는 본 발명의 조성물은 피부 미백을 위한 화장품, 멜라닌 색소 과다 침착 질환 개선용 건강기능식품 또는 멜라닌 색소 과다 침착 질환의 치료제로 유용하게 사용할 수 있다. The present invention relates to a composition for skin whitening containing a mixture of a fermented product of a ginseng leaf extract and a silver grass extract as an active ingredient, wherein the mixture of the fermented product of a ginseng leaf extract and a silver grass extract, which are active ingredients, has a tyrosinase inhibitory effect Since it has a remarkable effect compared to fermented ginseng leaf extract or silver grass extract, the composition of the present invention containing the active ingredient is a cosmetic for skin whitening, a health functional food for improving melanin hyperpigmentation disease, or a melanin hyperpigmentation disease. It can be useful as a therapeutic agent.
Description
본 발명은 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물을 유효성분으로 함유하는 피부 미백용 조성물에 관한 것이다. The present invention relates to a composition for skin whitening containing a mixture of a fermented product of a ginseng leaf extract and a silver grass extract as an active ingredient.
현대 사회에서 외모는 사회적 경쟁력 중 하나라는 인식이 증가하고 있으며, 의료 기술과 소득 수준이 향상됨에 따라 인간의 평균 수명이 증가하면서 건강한 삶과 아름다움에 대한 욕구가 강해지고 있다. 이러한 시대적 변화와 관심의 증가를 바탕으로 화장품 분야의 시장 규모는 빠른 속도로 확대되고 있으며, 이와 관련된 연구가 다각도로 진행되고 있다.In modern society, there is an increasing recognition that appearance is one of social competitiveness, and the desire for a healthy life and beauty is getting stronger as the average life expectancy of humans increases as medical technology and income levels improve. Based on these changes of the times and the increase in interest, the market size of the cosmetics field is rapidly expanding, and related research is being conducted from various angles.
특히 색소 침착형의 기미(melasma)나 주근깨(freckle)와 같은 피부미백에 대한 관심이 높아지고 있다. 사람의 피부색을 결정하는 데는 다양한 요인들이 관여하는데, 그 중에서도 멜라닌 색소를 만드는 멜라노사이트(melanocyte)의 활동성, 혈관의 분포, 피부의 두께 및 카로티노이드, 빌리루빈 등의 인체 내외의 색소 관련 요인들이 중요하다. In particular, interest in skin whitening, such as pigmentation-type melasma or freckles, is increasing. Various factors are involved in determining the skin color of a person. Among them, the activity of melanocytes that produce melanin pigment, the distribution of blood vessels, the thickness of skin, and pigment-related factors inside and outside the human body, such as carotenoids and bilirubin, are important.
그 중 가장 중요한 요인은 인체 내의 멜라노사이트에서 타이로시나제 등의 여러 효소가 작용하여 생성되는 멜라닌이라는 색소이다. 피부의 색소침착은 자외선이나 염증 등의 자극에 의해 야기되며 또 유전적 요인이나 호르몬, 식품 등과 화학물질 등의 인자에 의해서도 발생된다고 알려져 있다. 특히 기미, 주근깨, 색소침착 등과 같은 피부색소 이상침착 증상에 프로스타글란딘(prostaglandins), 히스타민(histamine), 알파-MSH(alpha-MSH), NO(Nitric oxide) 같은 염증 관련 인자가 관여되어 멜라노사이트(melanocyte) 내에서 멜라닌 생성을 활성화시키는 것은 잘 알려져 있다. 또한, 조직의 손상과 재생과정에서도 면역학적 매개체에 의해 과색소 침착이 수반된다는 보고도 있다. Among them, the most important factor is a pigment called melanin, which is produced by the action of various enzymes such as tyrosinase in melanocytes in the human body. It is known that pigmentation of the skin is caused by stimuli such as ultraviolet rays or inflammation, and also by factors such as genetic factors, hormones, foods, and chemicals. In particular, inflammation-related factors such as prostaglandins, histamine, alpha-MSH, and NO (Nitric oxide) are involved in abnormal skin pigmentation symptoms such as melasma, freckles, and pigmentation, resulting in melanocyte formation. ) is well known to activate melanin production in In addition, there is also a report that hyperpigmentation is accompanied by immunological mediators even in the process of tissue damage and regeneration.
멜라닌 색소 합성을 구체적으로 살펴보면 멜라닌 세포(melanocytes)가 여러 요인에 의해 자극을 받으면 티로시나아제(tyrosinase)가 멜라노좀(melanosome)에서 멜라닌을 생성한다. 즉, 멜라닌 세포 내 티로신은 티로시나아제의 작용으로 도파(dopa)로 변하고, 이어 도파옥시다제(dopaoxidase)의 작용으로 도파퀴논(dopaquinone)으로 변한 후, 티로시나아제 관련 단백질-1(tyrosinase-related protein-1, 이하 TRP-1이라고 함)과 티로시나아제 관련 단백질-2(tyrosinase-related protein-2, 이하 TRP-2이라고 함)의 작용에 의하여 멜라닌을 생성한다. 이러한 일련의 반응에서 티로시나아제는 멜라닌 색소 형성 과정의 속도-제한 반응을 활성화시키므로, 멜라닌 형성은 티로시나아제의 활성 및 발현에 의하여 1차적으로 제어된다. 또한, DOPA 크롬 상호변이효소로 알려진 TRP-2는 DOPA 크롬의 5,6-디하이드록시인돌-2-카르복실산(DHICA)로의 반응을 활성화시키고, TRP-1는 DHICA를 카르복실 인돌-퀴논으로 산화시킨다. 결과적으로 TRP-1 및 TRP-2는 불용성 색소인 멜라닌 형성의 최종단계인 중합반응에 관여한다. 이들 티로시나아제(tyrosinase), TRP-1(tyrosinase-related protein-1), TRP-2(tyrosinase-related protein-2)는 염증 매개물질에 의해 활성이 증가되어 멜라닌의 합성이 증가된다는 보고가 있다.Looking at melanin pigment synthesis in detail, when melanocytes are stimulated by various factors, tyrosinase produces melanin in melanosomes. That is, tyrosine in melanocytes is converted into dopa by the action of tyrosinase, then converted into dopaquinone by the action of dopaoxidase, and then tyrosinase-related protein-1 (tyrosinase-related protein-1). Melanin is produced by the action of protein-1 (hereinafter referred to as TRP-1) and tyrosinase-related protein-2 (hereinafter referred to as TRP-2). In this series of reactions, since tyrosinase activates the rate-limiting reaction of the melanin pigment formation process, melanin formation is primarily controlled by the activity and expression of tyrosinase. In addition, TRP-2, known as DOPA chromium transmutase, activates the reaction of DOPA chromium to 5,6-dihydroxyindole-2-carboxylic acid (DHICA), and TRP-1 converts DHICA to carboxyl indole-quinone. oxidize to As a result, TRP-1 and TRP-2 are involved in the polymerization reaction, which is the final stage of formation of melanin, an insoluble pigment. It has been reported that these tyrosinase, TRP-1 (tyrosinase-related protein-1), and TRP-2 (tyrosinase-related protein-2) increase their activity by inflammatory mediators and increase the synthesis of melanin. .
현재 개발된 미백제로는 코지산, 알부틴, 글루타치온, 비타민 C 등이 있지만 소비자들이 만족할 만한 미백효과를 갖지 못하고 있으며, 피부 안전성 때문에 그 사용량이 제한적이다. 따라서 안정성이 검증된 천연물 소재를 이용하여 피부 미백에 효과적인 화장품 제품의 개발에 대한 요구가 증대하고 있다.Currently developed whitening agents include kojic acid, arbutin, glutathione, vitamin C, etc., but they do not have a whitening effect satisfactory to consumers, and their usage is limited due to skin safety. Therefore, there is an increasing demand for the development of cosmetic products effective for skin whitening using natural materials whose stability has been verified.
한편, 한국등록특허 제2295904호에 개병풍 꽃 추출물 또는 이의 분획물을 유효성분으로 포함하는 피부 미백용 화장료 조성물이 개시되어 있고, 한국등록특허 제1936294호에 애기수영 또는 산수국의 추출물을 유효성분으로 함유하는 주름개선 또는 피부 미백용 조성물이 개시되어 있으나, 본 발명의 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물을 유효성분으로 함유하는 피부 미백용 조성물에 관해 개시된 바 없다. On the other hand, Korean Patent No. 2295904 discloses a cosmetic composition for skin whitening containing an extract or a fraction thereof as an active ingredient, and Korean Patent No. 1936294 discloses an extract of A. However, a composition for skin whitening containing a mixture of a fermented product of the ginseng leaf extract and a silver grass extract of the present invention as an active ingredient has not been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로, 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물을 유효성분으로 함유하는 피부 미백용 조성물을 제공하고, 상기 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물의 피부 미백 효과를 확인함으로써, 본 발명을 완성하였다.The present invention has been derived from the above needs, and provides a composition for skin whitening containing a mixture of a fermented ginseng leaf extract and a silver grass extract as an active ingredient, and a mixture of the fermented ginseng leaf extract and a silver grass extract. By confirming the skin whitening effect of, the present invention was completed.
상기 과제를 해결하기 위하여, 본 발명은 인삼잎 추출물의 발효물 및 억새(Miscanthus sinensis) 추출물의 혼합물을 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공한다. In order to solve the above problems, the present invention provides a cosmetic composition for skin whitening containing a mixture of fermented ginseng leaf extract and silver grass ( Miscanthus sinensis ) extract as an active ingredient.
또한, 본 발명은 인삼잎 추출물의 발효물 및 억새(Miscanthus sinensis) 추출물의 혼합물을 유효성분으로 함유하는 멜라닌 색소 과다 침착 질환의 예방 또는 개선용 건강기능식품 조성물을 제공한다. In addition, the present invention provides a health functional food composition for preventing or improving melanin hyperpigmentation disease containing a mixture of fermented ginseng leaf extract and silver grass extract ( Miscanthus sinensis ) as an active ingredient.
또한, 본 발명은 인삼잎 추출물의 발효물 및 억새(Miscanthus sinensis) 추출물의 혼합물을 유효성분으로 함유하는 멜라닌 색소 과다 침착 질환의 예방 또는 치료용 약학 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for the prevention or treatment of melanin hyperpigmentation disease containing a mixture of fermented ginseng leaf extract and silver grass extract ( Miscanthus sinensis ) as an active ingredient.
본 발명은 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물을 유효성분으로 함유하는 피부 미백용 조성물에 관한 것으로, 상기 유효성분인 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물의 티로시나아제 억제 효과가 인삼잎 추출물의 발효물 또는 억새 추출물에 비해 현저한 효과가 있으므로, 상기 유효성분을 함유하는 본 발명의 조성물은 피부 미백을 위한 화장료 조성물, 멜라닌 색소 과다 침착 질환의 예방 또는 개선용 건강기능식품 조성물 또는 멜라닌 색소 과다 침착 질환의 예방 또는 치료용 약학 조성물로 유용하게 사용할 수 있다. The present invention relates to a composition for skin whitening containing a mixture of a fermented product of a ginseng leaf extract and a silver grass extract as an active ingredient, wherein the mixture of the fermented product of a ginseng leaf extract and a silver grass extract, which are active ingredients, has a tyrosinase inhibitory effect Since it has a remarkable effect compared to fermented ginseng leaf extract or silver grass extract, the composition of the present invention containing the active ingredient is a cosmetic composition for skin whitening, a health functional food composition for preventing or improving melanin hyperpigmentation disease, or melanin It can be usefully used as a pharmaceutical composition for preventing or treating hyperpigmentation diseases.
도 1은 본 발명의 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물의 티로시나아제 억제 효과를 확인한 결과이다. @는 인삼 추출물의 발효물 대비 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물의 티로시나아제 억제 활성이 통계적으로 유의미하게 증가하였다는 것을 의미하며, p<0.05이다. **은 억새 추출물 대비 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물의 티로시나아제 억제 활성이 통계적으로 유의미하게 증가하였다는 것을 의미하며, p<0.01이다.1 is a result confirming the tyrosinase inhibitory effect of the mixture of the fermented product of the ginseng leaf extract and the silver grass extract of the present invention. @ means that the tyrosinase inhibitory activity of the mixture of the fermented product of the ginseng leaf extract and the silver grass extract was statistically significantly increased compared to the fermented product of the ginseng extract, p <0.05. ** means that the tyrosinase inhibitory activity of the mixture of the fermented product of the ginseng leaf extract and the silver grass extract was statistically significantly increased compared to the silver grass extract, p <0.01.
본 발명의 목적을 제공하기 위하여, 본 발명은 인삼잎 추출물의 발효물 및 억새(Miscanthus sinensis) 추출물의 혼합물을 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공한다. In order to provide the object of the present invention, the present invention provides a cosmetic composition for skin whitening containing a mixture of fermented ginseng leaf extract and silver grass ( Miscanthus sinensis ) extract as an active ingredient.
본 발명에서 피부 미백 효과란, 자외선 노출, 호르몬 밸런스의 변화, 유전적 프로그램 등의 각종 요인에 의해 발생하는 거뭇한 피부나 기미, 주근깨, 다크서클을 개선 또는 방지하는 효과, 피부를 투명감 있는 아름다운 것으로 하는, 혹은 투명감 있는 아름다운 피부를 유지하는 효과, 피부의 칙칙함을 경감하여 윤기ㆍ팽팽함을 증가시키는 효과 등을 의미한다.In the present invention, the skin whitening effect is an effect of improving or preventing dark skin, melasma, freckles, and dark circles caused by various factors such as exposure to ultraviolet rays, changes in hormonal balance, and genetic programs, and making the skin transparent and beautiful. It refers to the effect of maintaining beautiful skin with a sense of clearness or transparency, the effect of reducing the dullness of the skin and increasing the luster and tightness of the skin.
상기 추출물의 용매는 물, C1~C4의 저급 알코올 또는 이들의 혼합물일 수 있고, 바람직하게는 인삼잎 추출물의 용매는 물이고, 억새 추출물의 용매는 에탄올인 것이지만, 이에 제한되는 것은 아니다. The solvent of the extract may be water, C 1 ~ C 4 lower alcohol, or a mixture thereof, preferably, the solvent of the ginseng leaf extract is water, and the solvent of the silver grass extract is ethanol, but is not limited thereto.
상기 혼합물은 인삼잎 추출물의 발효물:억새 추출물이 6:3~25 중량비로 혼합된 것일 수 있고, 바람직하게는 인삼잎 추출물의 발효물:억새 추출물이 6:3~10 중량비로 혼합된 것일 수 있고, 더 바람직하게는 인삼잎 추출물의 발효물:억새 추출물이 6:3~5 중량비로 혼합된 것일 수 있으며, 가장 바람직하게는 인삼잎 추출물의 발효물:억새 추출물이 6:4 중량비로 혼합된 것이지만, 이에 제한되는 것은 아니다. The mixture may be a mixture of fermented ginseng leaf extract: silver grass extract in a weight ratio of 6:3 to 25, preferably a fermented product of ginseng leaf extract: silver grass extract in a weight ratio of 6:3 to 10 More preferably, fermented product of ginseng leaf extract: silver grass extract may be mixed in a weight ratio of 6: 3 to 5, and most preferably fermented product of ginseng leaf extract: silver grass extract mixed in a weight ratio of 6: 4 but is not limited thereto.
상기 인삼잎 추출물의 발효물은 인삼잎 추출물에 류코노스톡 시트레움(Leuconostoc citreum)을 접종하여 발효한 것일 수 있고, 바람직하게는 인삼잎 추출물에 류코노스톡 시트레움 KCTC3526을 접종하여 발효한 것일 수 있으며, 더욱 바람직하게는 인삼잎 추출물에 류코노스톡 시트레움 KCTC3526을 접종한 후 35~40℃에서 48~96시간 동안 발효한 것일 수 있으며, 가장 바람직하게는 인삼잎 추출물에 류코노스톡 시트레움 KCTC3526을 접종한 후 37℃에서 72시간 동안 발효한 것이지만, 이에 제한되는 것은 아니다. The fermented product of the ginseng leaf extract may be fermented by inoculating the ginseng leaf extract with Leuconostoc citreum, and preferably fermented by inoculating the ginseng leaf extract with Leuconostoc citreum KCTC3526 More preferably, after inoculating ginseng leaf extract with Leuconostoc citreum KCTC3526, it may be fermented for 48 to 96 hours at 35 ~ 40 ℃, most preferably, Leuconostoc citreum KCTC3526 in ginseng leaf extract After inoculation, it was fermented at 37 ° C. for 72 hours, but is not limited thereto.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있고, 보다 상세하게는, 스킨, 스킨 소프트너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐로션, 영양로션, 마사지크림, 영양크림, 아이 크림, 모이스쳐 크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징폼, 클렌징 워터, 클렌징 로션, 클렌징 크림, 바디로션, 바디클렌져, 비누 또는 파우더의 화장품 제형으로 제조될 수 있으나, 이에 한정하는 것은 아니다. The cosmetic composition of the present invention can be prepared in any formulation commonly prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, oil, powder foundation, emulsion It can be formulated into foundation, wax foundation and spray, etc., and more specifically, skin, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrient lotion, massage cream, nutrient cream, eye cream, Moisture cream, hand cream, essence, nutrient essence, pack, cleansing foam, cleansing water, cleansing lotion, cleansing cream, body lotion, body cleanser, soap or powder may be manufactured in cosmetic formulations, but is not limited thereto.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide as a carrier component this can be used
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로 히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the cosmetic composition of the present invention is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additionally chlorofluorohydro propellants such as carbon, propane/butane or dimethyl ether.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, solubilizing agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene fatty acid esters of glycol, 1,3-butylglycol oil, glycerol aliphatic esters, polyethylene glycol or sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, an ethoxylated isostearyl alcohol, a suspending agent such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester , microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracanth, and the like can be used.
본 발명의 화장료 조성물은 상기 유효성분 이외에 화장품 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온 봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭과 같은 통상적인 보조제, 그리고 담체를 포함한다.The cosmetic composition of the present invention includes ingredients commonly used in cosmetic compositions in addition to the above active ingredients, such as fatty substances, organic solvents, solubilizers, thickeners and gelling agents, softeners, antioxidants, suspending agents, stabilizers, foaming agents ( foaming agents), fragrances, surfactants, water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, humectants, essential oils, dyes, pigments, hydrophilic or lipophilic actives , conventional adjuvants such as lipid vesicles, and carriers.
또한, 본 발명은 인삼잎 추출물의 발효물 및 억새(Miscanthus sinensis) 추출물의 혼합물을 유효성분으로 함유하는 멜라닌 색소 과다 침착 질환의 예방 또는 개선용 건강기능식품 조성물을 제공한다. In addition, the present invention provides a health functional food composition for preventing or improving melanin hyperpigmentation disease containing a mixture of fermented ginseng leaf extract and silver grass extract ( Miscanthus sinensis ) as an active ingredient.
본 명세서에서 사용되는 용어 "멜라닌 색소 과다 침착(hyperpigmentation)"은 피부 또는 손발톱의 특정 부위에서 멜라닌의 과도한 증가에 의해 다른 부위에 비해 검게 또는 어둡게 되는 것을 의미한다. 상기 멜라닌 색소 과다 침착 질환은 주근깨, 노인성 반점, 간반, 기미, 갈색 또는 흑점, 일광 색소반, 푸른흑피증(cyanic melasma), 약물 사용 후의 과다 색소 침착; 찰상, 화상 또는 피부염으로 인한 염증 후 과다 색소 침착; 또는 임신성 갈색반(gravidic chloasma) 등을 포함하나 이에 한정되지 않는다.As used herein, the term “melanin hyperpigmentation” means that certain parts of the skin or nails become black or darker than other parts due to an excessive increase in melanin. The melanin hyperpigmentation diseases include freckles, senile spots, liver spots, melasma, brown or dark spots, solar pigment spots, cyanic melasma, hyperpigmentation after drug use; post-inflammatory hyperpigmentation due to scratches, burns or dermatitis; or gestational brown spots (gravidic chloasma), etc., but are not limited thereto.
본 발명의 건강기능식품 조성물을 식품첨가물로 사용하는 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분의 양은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. When using the health functional food composition of the present invention as a food additive, the health functional food composition may be added as it is or used together with other foods or food ingredients, and may be appropriately used according to conventional methods. The amount of the active ingredient can be appropriately used depending on the purpose of its use (prevention or improvement).
상기 건강기능식품의 종류에 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the type of health functional food. Examples of foods to which the health functional food composition can be added include meat, sausages, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea There are drinks, alcoholic beverages, and vitamin complexes, and includes all health foods in a conventional sense.
또한, 본 발명의 건강기능식품 조성물은 식품, 특히 기능성 식품으로 제조될 수 있다. 본 발명의 기능성 식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함할 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다.In addition, the health functional food composition of the present invention can be made into food, particularly functional food. The functional food of the present invention includes components commonly added during food preparation, and includes, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, when prepared as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to active ingredients. The natural carbohydrates are monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrins, cyclodextrins, etc.) or sugar alcohols (eg, maltose, sucrose, etc.) , xylitol, sorbitol, erythritol, etc.) are preferred. As the flavoring agent, natural flavoring agents (eg, thaumatin, stevia extract, etc.) and synthetic flavoring agents (eg, saccharin, aspartame, etc.) may be used.
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. 이러한 상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 조성물 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the health functional food composition, various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonic acid It may further contain a carbonation agent used in beverages and the like. The ratio of the components to be added is not very important, but is generally selected in the range of 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food composition of the present invention.
또한, 본 발명은 인삼잎 추출물의 발효물 및 억새(Miscanthus sinensis) 추출물의 혼합물을 유효성분으로 함유하는 멜라닌 색소 과다 침착 질환의 예방 또는 치료용 약학 조성물을 제공한다.In addition, the present invention provides a pharmaceutical composition for the prevention or treatment of melanin hyperpigmentation disease containing a mixture of fermented ginseng leaf extract and silver grass extract ( Miscanthus sinensis ) as an active ingredient.
본 발명의 약학조성물은 유효성분 이외에 약학적으로 허용되는 담체를 포함할 수 있으며, 이러한 담체는 제제 시에 통상적으로 이용되는 것으로서, 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산 칼슘, 알기네이트, 젤라틴, 규산 칼슘, 미세결정성 셀룰로스, 폴리비닐피롤리돈, 셀룰로스, 물, 시럽, 메틸 셀룰로스, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 활석, 스테아르산 마그네슘 및 미네랄 오일 등을 포함하나, 이에 한정되는 것은 아니다. 본 발명의 약학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등을 추가로 포함할 수 있다. The pharmaceutical composition of the present invention may include pharmaceutically acceptable carriers in addition to active ingredients, and such carriers are commonly used in preparation, and include lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum acacia, Calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and minerals. oils and the like, but are not limited thereto. The pharmaceutical composition of the present invention may further include a lubricant, a wetting agent, a sweetening agent, a flavoring agent, an emulsifying agent, a suspending agent, a preservative, and the like in addition to the above components.
본 발명에 따른 약학조성물의 적합한 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있다. A suitable dosage of the pharmaceutical composition according to the present invention is variously prescribed depending on factors such as formulation method, administration method, patient's age, weight, sex, pathological condition, food, administration time, administration route, excretion rate and response sensitivity. It can be.
본 발명의 약학조성물은 경구 또는 비경구로 투여할 수 있으며, 비경구 투여의 경우, 피부에 국소적으로 도포, 정맥 내 주입, 피하 주입, 근육 주입, 복강 주입, 경피 투여 등으로 투여할 수 있다. 본 발명의 약학조성물이 멜라닌 색소 과다 침착 질환을 치료 또는 예방을 위해 적용되는 점을 감안하면, 피부에 국소적으로 도포되어 이루어지는 것이 바람직하다.The pharmaceutical composition of the present invention can be administered orally or parenterally, and in the case of parenteral administration, it can be administered by topical application to the skin, intravenous injection, subcutaneous injection, intramuscular injection, intraperitoneal injection, transdermal administration, etc. Considering that the pharmaceutical composition of the present invention is applied for the treatment or prevention of melanin hyperpigmentation disease, it is preferably applied topically to the skin.
본 발명의 조성물에 포함되는 유효성분의 농도는 치료 목적, 환자의 상태, 필요기간 등을 고려하여 결정할 수 있으며 특정 범위의 농도로 한정되지 않는다.The concentration of the active ingredient included in the composition of the present invention can be determined in consideration of the purpose of treatment, the condition of the patient, the required period, etc., and is not limited to a specific range of concentration.
본 발명의 약학조성물은 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 약학적으로 허용되는 담체 또는 부형제를 이용하여 제제화함으로써 단위 용량 형태로 제조되거나 또는 다용량 용기 내에 내입시켜 제조될 수 있다. 이때 제형은 주사제, 크림, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 및 카타플라스마제 중에서 선택된 어느 하나의 제형으로 제조될 수도 있으며, 분산제 또는 안정화제를 추가적으로 포함할 수 있다.The pharmaceutical composition of the present invention is prepared in unit dosage form by formulating it using a pharmaceutically acceptable carrier or excipient according to a method that can be easily performed by those skilled in the art, or It can be prepared by incorporating into a dose container. At this time, the formulation may be prepared as any one formulation selected from injections, creams, patches, sprays, ointments, warnings, lotions, liniments, pastas, and cataplasmas, and may additionally include a dispersing agent or a stabilizer. there is.
이하, 제조예 및 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 제조예 및 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다. Hereinafter, the present invention will be described in more detail using preparation examples and examples. These Preparation Examples and Examples are only for explaining the present invention in more detail, and it is obvious to those skilled in the art that the scope of the present invention is not limited thereto.
제조예 1. 인삼잎 추출물의 발효물Preparation Example 1. Fermented product of ginseng leaf extract
본 발명의 인삼잎은 세척하여 완전히 자연건조한 후 분쇄하여 사용하였다. 분쇄된 인삼잎 20g에 1L의 물을 첨가한 후 100℃에서 2시간 동안 열수 추출하였다. 그 후 고온고압 멸균기(autoclave)를 이용하여 멸균하였다. 그 후, 멸균된 인삼잎 열수 추출물에 O.D600 값이 0.6~0.8이 되도록 배양한 류코노스톡 시트레움(Leuconostoc citreum, KCTC3526) 배양액을 500mL 접종한 후 37℃에서 72시간 동안 발효한 다음 발효과정 종료 후 5분간 끓여 추가 발효가 일어나지 않도록 하였다. 상기 발효물은 여과지를 이용하여 여과한 후 감압농축기(EYELA evaporator)를 이용하여 용매를 제거한 후, 동결건조하여 영하 4℃에 보관하면서 실험의 시료로 사용하였다.The ginseng leaves of the present invention were washed, completely dried naturally, and then pulverized and used. After adding 1 L of water to 20 g of crushed ginseng leaves, hot water extraction was performed at 100 ° C. for 2 hours. After that, it was sterilized using an autoclave. Then, 500mL of Leuconostoc citreum (KCTC3526) culture medium cultured to an OD 600 value of 0.6 to 0.8 was inoculated into the sterilized ginseng leaf hot water extract, fermented at 37°C for 72 hours, and then the fermentation process was terminated After boiling for 5 minutes, additional fermentation was prevented from occurring. The fermented product was filtered using a filter paper, the solvent was removed using an EYELA evaporator, and then lyophilized and stored at
제조예 2. 억새 추출물Preparation Example 2. Silver grass extract
본 발명의 억새(Miscanthus sinensis)는 전초를 사용하였으며, 세척하여 완전히 자연건조한 후 분쇄하여 사용하였다. 분쇄된 억새 분말 20g에 80%(v/v) 에탄올 2L를 첨가한 후 72시간 동안 침지시켜 추출한 후 종이여과지로 여과하고, 여액을 감압농축기를 이용하여 용매를 완전히 제거한 후, 냉장보관하면서 실험의 시료로 사용하였다.The grass grass of the present invention ( Miscanthus sinensis ) used an outpost, was washed, completely dried naturally, and then pulverized and used. After adding 2L of 80% (v/v) ethanol to 20g of pulverized silver grass powder, soaking for 72 hours for extraction, filtering with paper filter paper, completely removing the solvent from the filtrate using a vacuum concentrator, and then storing it in a refrigerator for the experiment. was used as a sample.
제조예 3. 인삼잎 추출물의 발효물 및 억새 추출물의 혼합물Preparation Example 3. A mixture of fermented product of ginseng leaf extract and silver grass extract
상기 제조예 1의 인삼잎 추출물의 발효물과 제조예 2의 억새 추출물을 각각 물로 5000㎍/mL로 희석한 후, 인삼잎 추출물의 발효물:억새 추출물을 6:4, 4:6 또는 2:8 중량비로 혼합하였다.After diluting the fermented product of the ginseng leaf extract of Preparation Example 1 and the silver grass extract of Preparation Example 2 with water to 5000 μg/mL, respectively, the fermented product of the ginseng leaf extract: silver grass extract 6:4, 4:6 or 2: 8 by weight.
실시예 1. 티로시나아제 저해 활성Example 1. Tyrosinase inhibitory activity
미백 효능 평가를 위해, DOPA 산화억제능실험(DOPA oxidation inhibition assay)을 수행하였다. To evaluate the whitening efficacy, DOPA oxidation inhibition assay was performed.
구체적으로, 5000㎍/mL로 희석한 시료액 80㎕, 10mM의 L-DOPA(3,4-Dihydroxy- L-phenylalanine) 40㎕ 및 버섯 티로시나아제(125U/mL) 40㎕를 혼합한 후, 25℃에서 30분 동안 반응시킨 후, 생성된 DOPA 크롬(chrome)을 마이크로플레이트 리더기(microplate reader)를 이용하여 490nm에서 흡광도를 측정하였다. 티로시나아제를 첨가하지 않은 군을 공실험군, 시료 용액을 첨가하지 않은 군을 대조군으로 하여 하기 식 1으로 효소 활성 저해율을 구하였다. Specifically, after mixing 80 μl of the sample solution diluted to 5000 μg/mL, 40 μl of 10 mM L-DOPA (3,4-Dihydroxy-L-phenylalanine) and 40 μl of mushroom tyrosinase (125 U/mL), After reacting at 25° C. for 30 minutes, the absorbance of the DOPA chrome produced was measured at 490 nm using a microplate reader. The group to which tyrosinase was not added was used as a blank test group, and the group to which no sample solution was added was used as a control group, and the enzyme activity inhibition rate was calculated according to the following formula 1.
[식 1][Equation 1]
티로시나아제 활성 저해율(%)={100-(b-b')/(a-a')}X100Tyrosinase activity inhibition rate (%) = {100-(b-b')/(a-a')}X100
a: 공시료액의 반응 후의 흡광도a: Absorbance after reaction of blank sample solution
b: 시료액의 반응 후의 흡광도b: Absorbance after reaction of sample solution
a', b': 티로시나아제 대신 완충액으로 대체하여 측정한 흡광도a', b': absorbance measured by replacing tyrosinase with buffer
그 결과, 도 1에 개시된 바와 같이 인삼 추출물의 발효물 또는 억새 추출물에 비해 이들 혼합물의 티로시나아제 억제 활성이 현저하게 증가하는 것을 확인하였다. 특히, 인삼 추출물의 발효물:억새 추출물이 6:4 중량비로 혼합된 혼합물의 티로시나아제 억제 활성이 4:6, 2:8로 혼합된 혼합물에 비해 더욱 우수하였다.As a result, as shown in FIG. 1, it was confirmed that the tyrosinase inhibitory activity of these mixtures was significantly increased compared to the fermented product of ginseng extract or the silver grass extract. In particular, the tyrosinase inhibitory activity of the mixture in which the fermented product of ginseng extract and the extract of Pampas grass was mixed at a weight ratio of 6:4 was more excellent than that of the mixture mixed at a weight ratio of 4:6 and 2:8.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210127747A KR102549076B1 (en) | 2021-09-28 | 2021-09-28 | Composition for skin whitening comprising mixture of fermented ginseng leaf extract and Miscanthus sinensis extract as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210127747A KR102549076B1 (en) | 2021-09-28 | 2021-09-28 | Composition for skin whitening comprising mixture of fermented ginseng leaf extract and Miscanthus sinensis extract as effective component |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230046327A KR20230046327A (en) | 2023-04-06 |
KR102549076B1 true KR102549076B1 (en) | 2023-07-03 |
Family
ID=85918254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210127747A KR102549076B1 (en) | 2021-09-28 | 2021-09-28 | Composition for skin whitening comprising mixture of fermented ginseng leaf extract and Miscanthus sinensis extract as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102549076B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101475609B1 (en) | 2013-06-12 | 2014-12-23 | 중앙대학교 산학협력단 | Composition for whitening comprising extract of Miscanthus sinensis var. purpurascens |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101143432B1 (en) * | 2009-03-13 | 2012-05-14 | (주)금강트레이딩 | Cosmetic composition including an extract of Chelidonium Majus L. having skin whitening effect |
KR20130047040A (en) * | 2011-10-31 | 2013-05-08 | (주)아모레퍼시픽 | Composition for skin whitening containing chelidonium majus extracts and trihydroxyisoflavones |
KR101418778B1 (en) * | 2011-12-21 | 2014-07-16 | 한국식품연구원 | Fermented extract of ginseng leaf having whitening effect and producing method thereof |
KR102026783B1 (en) * | 2017-11-03 | 2019-09-30 | 대한민국 | Fermented Extract of Ginseng Leaf for Skin Whitening and manufacturing method thereof |
-
2021
- 2021-09-28 KR KR1020210127747A patent/KR102549076B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101475609B1 (en) | 2013-06-12 | 2014-12-23 | 중앙대학교 산학협력단 | Composition for whitening comprising extract of Miscanthus sinensis var. purpurascens |
Also Published As
Publication number | Publication date |
---|---|
KR20230046327A (en) | 2023-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3854379A1 (en) | Cosmetic composition comprising centella asiatica adventitious root extract as effective ingredient for skin whitening and wrinkle reduction | |
KR102149177B1 (en) | Vinegar with enhanced skin whitening effect using Aster scaber and Ficus carica and production method thereof | |
KR101453258B1 (en) | Health Functional Food Composition Comprising Red Ginseng Extract, Benincasa Hispida Extract, and Apios Americana Extract for Improving Skin Beauty | |
KR102223021B1 (en) | Cosmetic composition for ameliorating skin whitening and wrinkle comprising fermented Sophora flavescens extract as effective component | |
KR102549076B1 (en) | Composition for skin whitening comprising mixture of fermented ginseng leaf extract and Miscanthus sinensis extract as effective component | |
KR102576243B1 (en) | Composition for skin whitening comprising mixture of Chelidonium majus var. asiaticum extract, fermented ginseng leaf extract and Miscanthus sinensis extract as effective component | |
KR102301299B1 (en) | Skin-lightening Composition Using an Extract of Xanthium canadense | |
KR101858118B1 (en) | Composition for skin whitening comprising fermented Geomgangsong as effective component | |
KR102035188B1 (en) | Composition for skin whitening comprising Cacalia firma extract as effective component | |
KR101832169B1 (en) | Composition for skin whitening comprising extract of Picrasma quassioides as effective component | |
KR101761142B1 (en) | Skin-lightening Composition Using an Extract of Rumex acetosella | |
KR102515649B1 (en) | Cosmetic composition for skin whitening and anti-wrinkle comprising extract of steamed Polygonatum sibiricum as effective componenet | |
KR101971254B1 (en) | Composition for skin whitening comprising Pavetta indica extract as effective component | |
KR102374364B1 (en) | Skin-lightening Composition Using an Extract of Eleocharis ussuriensis | |
KR102615923B1 (en) | Skin-lightening Composition Using Xanthatin | |
KR102510149B1 (en) | Skin-lightening Composition Using an Extract of Schizophragma hydrangeoides | |
KR102198871B1 (en) | Composition for skin whitening comprising Cacalia firma extract produced by enzyme treatment as effective component | |
KR102416777B1 (en) | Composition comprising Carex scabrifolia extract | |
KR102240026B1 (en) | Composition for skin whitening comprising Rhododendron schippenbachii root extract as effective component | |
KR102239470B1 (en) | Composition for skin whitening comprising extract of fermented black rice with improved antioxidant activity as effective component | |
KR102215699B1 (en) | Antioxidant and whitening composition containing Thymus quinquecostatus oil as effective component | |
KR101931269B1 (en) | Composition for skin whitening comprising extract of roasted Alpinia katsumadai semen as effective component | |
KR102218472B1 (en) | Composition for Skin-lightening Using an Extract of Aconogonon micranthum | |
KR102105897B1 (en) | Skin whitening composition comprising Ainsliaea acerifolia extract produced by ultra high pressure homogenization as effective component | |
KR101823928B1 (en) | Composition for skin whitening comprising extract of Cynanchum ascyrifolium as effective component |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |